Identification of stage-specific breast markers using quantitative proteomics

Journal of Proteome Research

Volumn 12, Issue 12, 2013, Pages 5696-5708

  Shaheed, Sadr Ul ^a   Rustogi, Nitin ^a   Scally, Andrew ^a   Wilson, Julie ^b   Thygesen, Helene ^c   Loizidou, Maria A ^d   Hadjisavvas, Andreas ^d   Hanby, Andrew ^c   Speirs, Valerie ^c   Loadman, Paul ^a   Linforth, Richard ^e   Kyriacou, Kyriacos ^d   Sutton, Chris W ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^e BRADFORD ROYAL INFIRMARY   (United Kingdom)

Author keywords

breast cancer; DCIS; fibroadenoma; invasive carcinoma; iTRAQ; mass spectrometry; proteomics; tissue microarray; Western blotting

Indexed keywords

COFILIN 1; COPPER AMINE OXIDASE 3; ESTROGEN RECEPTOR; MEMBRANE PROTEIN; PROTEIN P23; TUMOR MARKER; UNCLASSIFIED DRUG; AMINE OXIDASE (COPPER CONTAINING); CFL1 PROTEIN, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; PROTEASOME; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN, P23;

ADULT; AGED; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; BIOINFORMATICS; BREAST BIOPSY; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST FIBROADENOMA; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNCTIONAL PROTEOMICS; GENE ACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; ITRAQ ASSAY; LIPID TRANSPORT; MASS SPECTROMETER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MULTIPLE REACTION MONITORING MASS SPECTROMETRY; ONCOGENE MYC; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; TISSUE MICROARRAY; VALIDATION STUDY; WESTERN BLOTTING; BREAST NEOPLASMS; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; CASE CONTROL STUDY; FIBROADENOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; LIPID METABOLISM; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEOMICS; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; COFILIN 1; FEMALE; FIBROADENOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPID METABOLISM; MIDDLE AGED; NEOPLASM STAGING; OXIDATION-REDUCTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; PROTEOLYSIS; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-MYC; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84890100187     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400662k     Document Type: Article

References (57)

1. Hery, C.; Ferlay, J.; Boniol, M.; Autier, P. Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations Ann. Oncol. 2008, 19 (5) 1009-18
2. Benson, J. R.; Jatoi, I. The global breast cancer burden Future Oncol. 2012, 8 (6) 697-702
3. Herschkowitz, J. I.; Simin, K.; Weigman, V. J.; Mikaelian, I.; Usary, J.; Hu, Z.; Rasmussen, K. E.; Jones, L. P.; Assefnia, S.; Chandrasekharan, S.; Backlund, M. G.; Yin, Y.; Khramtsov, A. I.; Bastein, R.; Quackenbush, J.; Glazer, R. I.; Brown, P. H.; Green, J. E.; Kopelovich, L.; Furth, P. A.; Palazzo, J. P.; Olopade, O. I.; Bernard, P. S.; Churchill, G. A.; Van Dyke, T.; Perou, C. M. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biol. 2007, 8 (5) R76
4. Curtis, C.; Shah, S. P.; Chin, S. F.; Turashvili, G.; Rueda, O. M.; Dunning, M. J.; Speed, D.; Lynch, A. G.; Samarajiwa, S.; Yuan, Y.; Graf, S.; Ha, G.; Haffari, G.; Bashashati, A.; Russell, R.; McKinney, S.; Group, M.; Langerod, A.; Green, A.; Provenzano, E.; Wishart, G.; Pinder, S.; Watson, P.; Markowetz, F.; Murphy, L.; Ellis, I.; Purushotham, A.; Borresen-Dale, A. L.; Brenton, J. D.; Tavare, S.; Caldas, C.; Aparicio, S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature 2012, 486 (7403) 346-52
5. Hanby, A. M. Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy Br. J. Cancer 2005, 92 (4) 613-7
6. Mokbel, K. Towards optimal management of ductal carcinoma in situ of the breast Eur. J. Surg. Oncol. 2003, 29 (2) 191-7
7. Sutton, C. W.; Rustogi, N.; Gurkan, C.; Scally, A.; Loizidou, M. A.; Hadjisavvas, A.; Kyriacou, K. Quantitative proteomic profiling of matched normal and tumor breast tissues J. Proteome Res. 2010, 9 (8) 3891-902
8. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-54
9. Perkins, D. N.; Pappin, D. J.; Creasy, D. M.; Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data Electrophoresis 1999, 20 (18) 3551-67
10. Simpkins, S. A.; Hanby, A. M.; Holliday, D. L.; Speirs, V. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts J. Pathol. 2012, 227 (4) 490-8
11. Collins, L. C.; Botero, M. L.; Schnitt, S. J. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases Am. J. Clin. Pathol. 2005, 123 (1) 16-20
12. Simpson, N. E.; Lambert, W. M.; Watkins, R.; Giashuddin, S.; Huang, S. J.; Oxelmark, E.; Arju, R.; Hochman, T.; Goldberg, J. D.; Schneider, R. J.; Reiz, L. F.; Soares, F. A.; Logan, S. K.; Garabedian, M. J. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance Cancer Res. 2010, 70 (21) 8446-56
13. Wulfkuhle, J. D.; Sgroi, D. C.; Krutzsch, H.; McLean, K.; McGarvey, K.; Knowlton, M.; Chen, S.; Shu, H.; Sahin, A.; Kurek, R.; Wallwiener, D.; Merino, M. J.; Petricoin, E. F., 3rd; Zhao, Y.; Steeg, P. S. Proteomics of human breast ductal carcinoma in situ Cancer Res. 2002, 62 (22) 6740-9
14. Kabbage, M.; Chahed, K.; Hamrita, B.; Guillier, C. L.; Trimeche, M.; Remadi, S.; Hoebeke, J.; Chouchane, L. Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry J. Biomed. Biotechnol. 2008, 2008, 564127
15. Celis, J. E.; Gromova, I.; Cabezon, T.; Gromov, P.; Shen, T.; Timmermans-Wielenga, V.; Rank, F.; Moreira, J. M. Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease Mol. Oncol. 2007, 1 (3) 321-49
16. Alix-Panabieres, C.; Vendrell, J. P.; Slijper, M.; Pelle, O.; Barbotte, E.; Mercier, G.; Jacot, W.; Fabbro, M.; Pantel, K. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer Breast Cancer Res. 2009, 11 (3) R39
17. Cimpean, A. M.; Suciu, C.; Ceausu, R.; Tatucu, D.; Muresan, A. M.; Raica, M. Relevance of the immunohistochemical expression of cytokeratin 8/18 for the diagnosis and classification of breast cancer Rom. J. Morphol. Embryol. 2008, 49 (4) 479-83
18. Kongara, S.; Kravchuk, O.; Teplova, I.; Lozy, F.; Schulte, J.; Moore, D.; Barnard, N.; Neumann, C. A.; White, E.; Karantza, V. Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors Mol. Cancer Res. 2010, 8 (6) 873-84
19. Debily, M. A.; Marhomy, S. E.; Boulanger, V.; Eveno, E.; Mariage-Samson, R.; Camarca, A.; Auffray, C.; Piatier-Tonneau, D.; Imbeaud, S. A functional and regulatory network associated with PIP expression in human breast cancer PLoS One 2009, 4 (3) e4696
20. Alexander, H.; Stegner, A. L.; Wagner-Mann, C.; Du Bois, G. C.; Alexander, S.; Sauter, E. R. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid Clin. Cancer Res. 2004, 10 (22) 7500-10
21. Lwin, Z. M.; Guo, C.; Salim, A.; Yip, G. W.; Chew, F. T.; Nan, J.; Thike, A. A.; Tan, P. H.; Bay, B. H. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma Mod. Pathol. 2010, 23 (12) 1559-66
22. Lee, H. H.; Lim, C. A.; Cheong, Y. T.; Singh, M.; Gam, L. H. Comparison of protein expression profiles of different stages of lymph nodes metastasis in breast cancer Int. J. Biol. Sci. 2012, 8 (3) 353-62
23. Miksicek, R. J.; Myal, Y.; Watson, P. H.; Walker, C.; Murphy, L. C.; Leygue, E. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium Cancer Res. 2002, 62 (10) 2736-40
24. Ayerbes, M. V.; Diaz-Prado, S.; Ayude, D.; Campelo, R. G.; Iglesias, P.; Haz, M.; Medina, V.; Gallegos, I.; Quindos, M.; Aparicio, L. A. In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer Adv. Exp. Med. Biol. 2008, 617, 331-9
25. Tamesa, M. S.; Kuramitsu, Y.; Fujimoto, M.; Maeda, N.; Nagashima, Y.; Tanaka, T.; Yamamoto, S.; Oka, M.; Nakamura, K. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis Electrophoresis 2009, 30 (12) 2168-81
26. Simpson, N. E.; Gertz, J.; Imberg, K.; Myers, R. M.; Garabedian, M. J. Research resource: enhanced genome-wide occupancy of estrogen receptor alpha by the cochaperone p23 in breast cancer cells Mol. Endocrinol. 2012, 26 (1) 194-202
27. Frasor, J.; Weaver, A. E.; Pradhan, M.; Mehta, K. Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines Endocrinology 2008, 149 (12) 6272-9
28. Ho, J.; Kong, J. W.; Choong, L. Y.; Loh, M. C.; Toy, W.; Chong, P. K.; Wong, C. H.; Wong, C. Y.; Shah, N.; Lim, Y. P. Novel breast cancer metastasis-associated proteins J. Proteome Res. 2009, 8 (2) 583-94
29. Rower, C.; Koy, C.; Hecker, M.; Reimer, T.; Gerber, B.; Thiesen, H. J.; Glocker, M. O. Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma J. Am. Soc. Mass Spectrom. 2011, 22 (3) 440-56
30. Gromov, P.; Gromova, I.; Bunkenborg, J.; Cabezon, T.; Moreira, J. M.; Timmermans-Wielenga, V.; Roepstorff, P.; Rank, F.; Celis, J. E. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast Mol. Oncol. 2010, 4 (1) 65-89
31. Caruso, J. A.; Stemmer, P. M. Proteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression Clin. Exp. Metastasis 2011, 28 (6) 529-40
32. Hancke, K.; Grubeck, D.; Hauser, N.; Kreienberg, R.; Weiss, J. M. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients Breast Cancer Res. Treat. 2010, 119 (2) 367-7
33. Tang, X. Y.; Umemura, S.; Tsukamoto, H.; Kumaki, N.; Tokuda, Y.; Osamura, R. Y. Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer Pathol. Res. Pract. 2010, 206 (2) 98-101
34. Harvell, D. M.; Spoelstra, N. S.; Singh, M.; McManaman, J. L.; Finlayson, C.; Phang, T.; Trapp, S.; Hunter, L.; Dye, W. W.; Borges, V. F.; Elias, A.; Horwitz, K. B.; Richer, J. K. Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance Breast Cancer Res. Treat. 2008, 112 (3) 475-88
35. Davalos, A.; Fernandez-Hernando, C.; Sowa, G.; Derakhshan, B.; Lin, M. I.; Lee, J. Y.; Zhao, H.; Luo, R.; Colangelo, C.; Sessa, W. C. Quantitative proteomics of caveolin-1-regulated proteins: characterization of polymerase I and transcript release factor/CAVIN-1 IN endothelial cells Mol. Cell. Proteomics 2010, 9 (10) 2109-24
36. Guerin, M.; Barrois, M.; Terrier, M. J.; Spielmann, M.; Riou, G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis Oncogene Res. 1988, 3 (1) 21-31
37. Wang, G.; Platt-Higgins, A.; Carroll, J.; de Silva Rudland, S.; Winstanley, J.; Barraclough, R.; Rudland, P. S. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients Cancer Res. 2006, 66 (2) 1199-207
38. Yuan, Y.; Nymoen, D. A.; Dong, H. P.; Bjorang, O.; Shih, Ie, M.; Low, P. S.; Trope, C. G.; Davidson, B. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions Hum. Pathol. 2009, 40 (10) 1453-60
39. Shatz, M.; Liscovitch, M. Caveolin-1: a tumor-promoting role in human cancer Int. J. Radiat. Biol. 2008, 84 (3) 177-89
40. Wang, W.; Eddy, R.; Condeelis, J. The cofilin pathway in breast cancer invasion and metastasis Nat. Rev. Cancer 2007, 7 (6) 429-40
41. Wang, W. S.; Zhong, H. J.; Xiao, D. W.; Huang, X.; Liao, L. D.; Xie, Z. F.; Xu, X. E.; Shen, Z. Y.; Xu, L. Y.; Li, E. M. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features Dis. Esophagus 2010, 23 (6) 512-21
42. Yang, Z. L.; Miao, X.; Xiong, L.; Zou, Q.; Yuan, Y.; Li, J.; Liang, L.; Chen, M.; Chen, S. CFL1 and Arp3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinomas of gallbladder Cancer Invest. 2013, 31 (2) 132-9
43. Zhou, J.; Wang, Y.; Fei, J.; Zhang, W. Expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer Oncol. Lett. 2012, 4 (6) 1187-1190
44. Nishimura, S.; Tsuda, H.; Kataoka, F.; Arao, T.; Nomura, H.; Chiyoda, T.; Susumu, N.; Nishio, K.; Aoki, D. Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy Hum. Pathol. 2011, 42 (4) 516-21
45. Muller, C. B.; de Barros, R. L.; Castro, M. A.; Lopes, F. M.; Meurer, R. T.; Roehe, A.; Mazzini, G.; Ulbrich-Kulczynski, J. M.; Dal-Pizzol, F.; Fernandes, M. C.; Moreira, J. C.; Xavier, L. L.; Klamt, F. Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort J. Cancer Res. Clin. Oncol. 2011, 137 (9) 1309-16
46. Castro, M. A.; Dal-Pizzol, F.; Zdanov, S.; Soares, M.; Muller, C. B.; Lopes, F. M.; Zanotto-Filho, A.; da Cruz Fernandes, M.; Moreira, J. C.; Shacter, E.; Klamt, F. CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer Cancer 2010, 116 (15) 3645-55
47. Turhani, D.; Krapfenbauer, K.; Thurnher, D.; Langen, H.; Fountoulakis, M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis Electrophoresis 2006, 27 (7) 1417-23
48. Wang, Y.; Kuramitsu, Y.; Ueno, T.; Suzuki, N.; Yoshino, S.; Iizuka, N.; Zhang, X.; Oka, M.; Nakamura, K. Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues Oncol. Rep. 2011, 26 (6) 1595-9
49. Unwin, R. D.; Craven, R. A.; Harnden, P.; Hanrahan, S.; Totty, N.; Knowles, M.; Eardley, I.; Selby, P. J.; Banks, R. E. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect Proteomics 2003, 3 (8) 1620-32
50. Sullivan, W.; Stensgard, B.; Caucutt, G.; Bartha, B.; McMahon, N.; Alnemri, E. S.; Litwack, G.; Toft, D. Nucleotides and two functional states of hsp90 J. Biol. Chem. 1997, 272 (12) 8007-12
51. Oxelmark, E.; Roth, J. M.; Brooks, P. C.; Braunstein, S. E.; Schneider, R. J.; Garabedian, M. J. The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion Mol. Cell. Biol. 2006, 26 (14) 5205-13
52. Toogun, O. A.; Dezwaan, D. C.; Freeman, B. C. The hsp90 molecular chaperone modulates multiple telomerase activities Mol. Cell. Biol. 2008, 28 (1) 457-67
53. Tanioka, T.; Nakatani, Y.; Kobayashi, T.; Tsujimoto, M.; Oh-ishi, S.; Murakami, M.; Kudo, I. Regulation of cytosolic prostaglandin E2 synthase by 90-kDa heat shock protein Biochem. Biophys. Res. Commun. 2003, 303 (4) 1018-23
54. Toninello, A.; Pietrangeli, P.; De Marchi, U.; Salvi, M.; Mondovi, B. Amine oxidases in apoptosis and cancer Biochim. Biophys. Acta 2006, 1765 (1) 1-13
55. Song, X.; Chen, X.; Yamaguchi, H.; Mouneimne, G.; Condeelis, J. S.; Eddy, R. J. Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells J. Cell. Sci. 2006, 119 (Pt 14) 2871-81
56. Reebye, V.; Querol Cano, L.; Lavery, D. N.; Brooke, G. N.; Powell, S. M.; Chotai, D.; Walker, M. M.; Whitaker, H. C.; Wait, R.; Hurst, H. C.; Bevan, C. L. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer Mol. Endocrinol. 2012, 26 (10) 1694-706
57. Goldblatt, E. M.; Gentry, E. R.; Fox, M. J.; Gryaznov, S. M.; Shen, C.; Herbert, B. S. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel Mol. Cancer Ther. 2009, 8 (7) 2027-35